Journal
/
/
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
DOI:

06:59 min

May 12, 2023

, , , ,

Chapters

  • 00:04Introduction
  • 00:56Sample Processing
  • 03:11Establishment of Zebrafish‐Based Patient‐Derived Xenografts (zPDX)
  • 04:56Treatment and Imaging
  • 05:40Results: Establishment of Zebrafish‐Based Patient‐Derived Xenografts (zPDXs) from Primary Human Pancreatic Adenocarcinoma
  • 06:14Conclusion

Summary

Automatic Translation

Preclinical models aim to advance the knowledge of cancer biology and predict treatment efficacy. This paper describes the generation of zebrafish-based patient-derived xenografts (zPDXs) with tumor tissue fragments. The zPDXs were treated with chemotherapy, the therapeutic effect of which was assessed in terms of cell apoptosis of the transplanted tissue.

Related Videos

Read Article